396 related articles for article (PubMed ID: 29439673)
41. Modulation of the surface expression of CD158 killer cell Ig-like receptor by interleukin-2 and transforming growth factor-beta.
Shin EC; Choi KS; Kim SJ; Shin JS
Yonsei Med J; 2004 Jun; 45(3):510-4. PubMed ID: 15227739
[TBL] [Abstract][Full Text] [Related]
42. HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.
Vingert B; Benati D; Lambotte O; de Truchis P; Slama L; Jeannin P; Galperin M; Perez-Patrigeon S; Boufassa F; Kwok WW; Lemaître F; Delfraissy JF; Thèze J; Chakrabarti LA
J Virol; 2012 Oct; 86(19):10661-74. PubMed ID: 22837194
[TBL] [Abstract][Full Text] [Related]
43. Immune Dysfunctions of CD56
Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
Front Immunol; 2021; 12():811091. PubMed ID: 35069597
[TBL] [Abstract][Full Text] [Related]
44. CD4
Zhang ZN; Bai LX; Fu YJ; Jiang YJ; Shang H
Cytokine; 2017 Mar; 91():110-117. PubMed ID: 28043029
[TBL] [Abstract][Full Text] [Related]
45. Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study.
Watanabe D; Uehira T; Suzuki S; Matsumoto E; Ueji T; Hirota K; Minami R; Takahama S; Hayashi K; Sawamura M; Yamamoto M; Shirasaka T
BMC Infect Dis; 2019 Jan; 19(1):11. PubMed ID: 30611204
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
Huang XL; Fan Z; Murayama T; Rinaldo C
Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
[TBL] [Abstract][Full Text] [Related]
47. Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma.
Yvon ES; Burga R; Powell A; Cruz CR; Fernandes R; Barese C; Nguyen T; Abdel-Baki MS; Bollard CM
Cytotherapy; 2017 Mar; 19(3):408-418. PubMed ID: 28109751
[TBL] [Abstract][Full Text] [Related]
48. Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.
Luo Z; Li Z; Martin L; Wan Z; Meissner EG; Espinosa E; Wu H; Yu X; Fu P; Julia Westerink MA; Kilby JM; Wu J; Huang L; Heath SL; Li Z; Jiang W
J Infect Dis; 2017 Jul; 216(1):82-91. PubMed ID: 28498953
[TBL] [Abstract][Full Text] [Related]
49. The effect of kisspeptin on the functional characteristics of isolated NK cells.
Shirshev SV; Nekrasova IV; Gorbunova OL; Orlova EG; Maslennikova IL
Dokl Biol Sci; 2015; 464():267-9. PubMed ID: 26530074
[TBL] [Abstract][Full Text] [Related]
50. [CYTOKINES DURING THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1(HIV-1)].
Selimova LM; Kalnina LB; Serebrovskaya LV; Ivanova LA; Gulyaeva AN; Nosik DN
Vopr Virusol; 2016; 61(1):39-41. PubMed ID: 27145600
[TBL] [Abstract][Full Text] [Related]
51. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
[TBL] [Abstract][Full Text] [Related]
52. Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.
Boulassel MR; Smith GH; Edwardes MD; Young M; Klein M; Gilmore N; Macleod J; Leblanc R; René P; Allan J; Lalonde RG; Routy JP
HIV Med; 2005 Jul; 6(4):268-77. PubMed ID: 16011532
[TBL] [Abstract][Full Text] [Related]
53. Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-beta production by NK cells and TGF-beta-mediated NK cell apoptosis.
Zocchi MR; Contini P; Alfano M; Poggi A
J Immunol; 2005 May; 174(10):6054-61. PubMed ID: 15879099
[TBL] [Abstract][Full Text] [Related]
54. Platelet-Derived Ectosomes Reduce NK Cell Function.
Sadallah S; Schmied L; Eken C; Charoudeh HN; Amicarella F; Schifferli JA
J Immunol; 2016 Sep; 197(5):1663-71. PubMed ID: 27448586
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-21 up-regulates interleukin-21R expression and interferon gamma production by CD8+ cells in SHIV-infected macaques.
Zhao CC; Gao XQ; Xue J; Cong Z; Zhang WL; Chen T; Wu FX; Xiong J; Ju B; Su A; Wei Q; Qin C
Exp Biol Med (Maywood); 2013 Apr; 238(4):400-9. PubMed ID: 23760006
[TBL] [Abstract][Full Text] [Related]
56. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.
Toka FN; Nfon CK; Dawson H; Estes DM; Golde WT
J Interferon Cytokine Res; 2009 Mar; 29(3):179-92. PubMed ID: 19196070
[TBL] [Abstract][Full Text] [Related]
57. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice.
Su HC; Ishikawa R; Biron CA
J Immunol; 1993 Nov; 151(9):4874-90. PubMed ID: 8409446
[TBL] [Abstract][Full Text] [Related]
59. Alteration of CD8+ T cell effector diversity during HIV-1 infection with discordant normalization in effective antiretroviral therapy.
Onlamoon N; Sukapirom K; Polsrila K; Ammaranond P; Pattanapanyasat K
Cytometry B Clin Cytom; 2012 Jan; 82(1):35-42. PubMed ID: 21915993
[TBL] [Abstract][Full Text] [Related]
60. Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs.
Jiang Y; Zhou F; Tian Y; Zhang Z; Kuang R; Liu J; Han X; Hu Q; Xu J; Shang H
J Clin Immunol; 2013 Nov; 33(8):1376-85. PubMed ID: 23996459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
